Home

Lisa Andrade

CIK 1595202 · VP and Chief Marketing Officer · last filed 2026-06-05

Lisa Andrade is a VP and Chief Marketing Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for NPCE, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$962.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $40.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$40.1K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$962.1K

Filer Profile

Reported Address
6300 BEE CAVE ROAD, BLDG 2, SUITE 100
AUSTIN, TX 78746
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NPCE Director 2,890 $13.87 $40.1K $0 6 2026-06-05
ST JUDE MEDICAL, LLC (STJ) Delisted VP and Chief Marketing Officer 10,060 — — -$962.1K 10 2016-12-20

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 NPCE Grant (A) +2,890 $0 EDGAR
2025-06-09 NPCE Grant (A) — $0 EDGAR
2024-06-11 NPCE Grant (A) — $0 EDGAR
2023-06-14 NPCE Grant (A) — $0 EDGAR
2022-06-21 NPCE Grant (A) — $0 EDGAR
2021-11-02 NPCE Grant (A) — $0 EDGAR
2017-01-06 — Disp (D) −10,302 $0
2016-12-20 ST JUDE MEDICAL, LLC (STJ) Delisted Mixed +1,975 -$59.6K EDGAR
2016-12-19 ST JUDE MEDICAL, LLC (STJ) Delisted Mixed +672 -$20.3K EDGAR
2015-12-21 ST JUDE MEDICAL, LLC (STJ) Delisted Mixed +1,832 -$42.7K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.